Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 127

1.

Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours - a clinical physics perspective.

Lambrecht M, Melidis C, Sonke JJ, Adebahr S, Boellaard R, Verheij M, Guckenberger M, Nestle U, Hurkmans C.

Radiat Oncol. 2016 Jan 20;11(1):7. doi: 10.1186/s13014-015-0567-5.

2.

Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group.

Thibault I, Chang EL, Sheehan J, Ahluwalia MS, Guckenberger M, Sohn MJ, Ryu S, Foote M, Lo SS, Muacevic A, Soltys SG, Chao S, Gerszten P, Lis E, Yu E, Bilsky M, Fisher C, Schiff D, Fehlings MG, Ma L, Chang S, Chow E, Parelukar WR, Vogelbaum MA, Sahgal A.

Lancet Oncol. 2015 Dec;16(16):e595-603. doi: 10.1016/S1470-2045(15)00166-7. Review.

PMID:
26678212
3.

Spinal metastases: Is stereotactic body radiation therapy supported by evidences?

De Bari B, Alongi F, Mortellaro G, Mazzola R, Schiappacasse L, Guckenberger M.

Crit Rev Oncol Hematol. 2016 Feb;98:147-58. doi: 10.1016/j.critrevonc.2015.11.002. Epub 2015 Nov 10. Review.

PMID:
26597017
4.

Evaluation of an automated knowledge based treatment planning system for head and neck.

Krayenbuehl J, Norton I, Studer G, Guckenberger M.

Radiat Oncol. 2015 Nov 10;10:226. doi: 10.1186/s13014-015-0533-2.

5.

[Abscopal responses of local radiotherapy combined with systemic immunotherapy in patients with metastatic solid tumors].

Panje C, Guckenberger M.

Strahlenther Onkol. 2016 Jan;192(1):72-4. doi: 10.1007/s00066-015-0921-4. German. No abstract available.

PMID:
26545761
6.

Dose and Fractionation in Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: Lessons Learned and Where Do We Go Next?

Guckenberger M.

Int J Radiat Oncol Biol Phys. 2015 Nov 15;93(4):765-8. doi: 10.1016/j.ijrobp.2015.08.025. Epub 2015 Oct 19. No abstract available.

PMID:
26530744
7.

Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10.

Ghadjar P, Hayoz S, Bernhard J, Zwahlen DR, Hölscher T, Gut P, Guckenberger M, Hildebrandt G, Müller AC, Plasswilm L, Papachristofilou A, Stalder L, Biaggi-Rudolf C, Sumila M, Kranzbühler H, Najafi Y, Ost P, Azinwi NC, Reuter C, Bodis S, Kaouthar K, Wust P, Thalmann GN, Aebersold DM.

J Clin Oncol. 2015 Dec 10;33(35):4158-66. doi: 10.1200/JCO.2015.63.3529. Epub 2015 Nov 2.

PMID:
26527774
8.

[Randomised comparison of stereotactic body radiotherapy versus lobectomy in stage I NSCLC-level I evidence at last?].

Guckenberger M, Andratschke N.

Strahlenther Onkol. 2015 Dec;191(12):988-90. doi: 10.1007/s00066-015-0905-4. German. No abstract available.

PMID:
26459463
9.

Tumor stage, tumor site and HPV dependent correlation of perfusion CT parameters and [18F]-FDG uptake in head and neck squamous cell carcinoma.

Nesteruk M, Lang S, Veit-Haibach P, Studer G, Stieb S, Glatz S, Hemmatazad H, Ikenberg K, Huber G, Pruschy M, Guckenberger M, Klöck S, Riesterer O.

Radiother Oncol. 2015 Oct;117(1):125-31. doi: 10.1016/j.radonc.2015.09.026.

PMID:
26452710
10.

Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy.

Guckenberger M, Klement RJ, Allgäuer M, Andratschke N, Blanck O, Boda-Heggemann J, Dieckmann K, Duma M, Ernst I, Ganswindt U, Hass P, Henkenberens C, Holy R, Imhoff D, Kahl HK, Krempien R, Lohaus F, Nestle U, Nevinny-Stickel M, Petersen C, Semrau S, Streblow J, Wendt TG, Wittig A, Flentje M, Sterzing F.

Radiother Oncol. 2015 Sep 15. pii: S0167-8140(15)00466-1. doi: 10.1016/j.radonc.2015.09.008. [Epub ahead of print]

PMID:
26385265
11.

Tumour delineation in oesophageal cancer - A prospective study of delineation in PET and CT with and without endoscopically placed clip markers.

Thomas L, Lapa C, Bundschuh RA, Polat B, Sonke JJ, Guckenberger M.

Radiother Oncol. 2015 Aug;116(2):269-75. doi: 10.1016/j.radonc.2015.07.007. Epub 2015 Sep 10.

PMID:
26364886
12.

The development of stereotactic body radiotherapy in the past decade: a global perspective.

Lo SS, Slotman BJ, Lock M, Nagata Y, Guckenberger M, Siva S, Foote M, Tan D, Teh BS, Mayr NA, Chang EL, Timmerman RD, Sahgal A.

Future Oncol. 2015 Sep 4. [Epub ahead of print]

PMID:
26338676
13.

Differential DNA repair pathway choice in cancer cells after proton- and photon-irradiation.

Fontana AO, Augsburger MA, Grosse N, Guckenberger M, Lomax AJ, Sartori AA, Pruschy MN.

Radiother Oncol. 2015 Sep;116(3):374-80. doi: 10.1016/j.radonc.2015.08.014. Epub 2015 Aug 25.

PMID:
26320609
14.
15.

Three-dimensional versus four-dimensional dose calculation for volumetric modulated arc therapy of hypofractionated treatments.

Ehrbar S, Lang S, Stieb S, Riesterer O, Stark LS, Guckenberger M, Klöck S.

Z Med Phys. 2015 Jul 14. pii: S0939-3889(15)00072-0. doi: 10.1016/j.zemedi.2015.06.010. [Epub ahead of print]

PMID:
26187810
16.

Radiation holidays stimulate tumor immunity.

Surace L, Guckenberger M, van den Broek M.

Oncotarget. 2015 Jun 30;6(18):15716-7. No abstract available.

17.

Stereotactic body radiotherapy for central lung tumours: Author reply.

Adebahr S, Collette S, Shash E, Lambrecht M, Le Pechoux C, Faivre-Finn C, De Ruysscher D, Peulen H, Belderbos J, Dziadziuszko R, Fink C, Guckenberger M, Hurkmans C, Nestle U.

Br J Radiol. 2015 Sep;88(1053):20150532. doi: 10.1259/bjr.20150532. Epub 2015 Jul 7. No abstract available.

PMID:
26151618
18.

[Oligoprogression].

Guckenberger M.

Strahlenther Onkol. 2015 May;191(5):453-5. doi: 10.1007/s00066-015-0826-2. German. No abstract available.

PMID:
26120651
19.

SBRT Dose and Survival in Non-Small Cell Lung Cancer: In Regard to Koshy et al.

Levy A, Guckenberger M, Hurkmans C, Nestle U, Belderbos J, De Ruysscher D, Faivre-Finn C, Le Péchoux C.

Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):945-6. doi: 10.1016/j.ijrobp.2015.03.032. No abstract available.

PMID:
26104945
20.

LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective.

Adebahr S, Collette S, Shash E, Lambrecht M, Le Pechoux C, Faivre-Finn C, De Ruysscher D, Peulen H, Belderbos J, Dziadziuszko R, Fink C, Guckenberger M, Hurkmans C, Nestle U.

Br J Radiol. 2015 Jul;88(1051):20150036. doi: 10.1259/bjr.20150036. Epub 2015 Apr 15.

PMID:
25873481
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk